Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Super Biotech Co., Ltd. is a biotechnology company based in Haikou, China, specializing in the development and large-scale production of recombinant humanized collagen. As a key industrialization base for its parent company, Beijing Super Biotech, it utilizes synthetic biology and high-density fermentation platforms to create high-purity collagen proteins. The company's pipeline includes recombinant humanized Type III, Type I, and Type XVII collagens, which serve as advanced biomaterials for medical aesthetics, regenerative medicine, and wound care. Hainan Super Biotech's facilities in the Hainan National High-tech Zone are designed to meet GMP standards for the commercialization of these innovative biologics. By replacing animal-derived collagen, the company provides safer and more effective solutions for tissue engineering and clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Super Biotech.